Impact of uricosurics on mortality outcomes in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
Chia Siang Chia KowDinesh Sangarran RamachandramSyed Shahzad HasanKaeshaelya ThiruchelvamPublished in: The International journal of pharmacy practice (2024)
The findings confirmed the safety of uricosurics in COVID-19 patients, despite their potential to cause uric acid excretion, which may possess antioxidant properties.